Endothelial dysfunction and denudation in rat aortic allografts

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 1, 2001, Pages 67-73

  Andriambeloson, Emile ^a   Bigaud, Marc ^a   Schraa, Edo O ^a   Kobel, Tanja ^a   Lobstein, Valerie ^a   Pally, Charles ^a   Zerwes, Hans Günter ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aorta; Endothelium; Graft; Rejection; Vasorelaxation

Indexed keywords

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; AORTA GRAFT; ARTICLE; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CONTROLLED STUDY; ENDOTHELIUM CELL; LEUKOCYTE ADHERENCE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RAT; SILVER STAINING; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0035162769     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.1.67     Document Type: Article

References (33)

1. Chronic allograft failure: The clinical problem
2. Cardiac allograft vasculopathy: Review
3. The problem of chronic rejection: Influence of leukocyteendothelial interactions
4. Role of endothelial cells in transplantation
5. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant
6. Endothelial activation and development of coronary artery disease in transplanted human hearts
7. Chronic rejection in rat aortic allografts: An experimental model for transplant arteriosclerosis
8. Clinical and experimental chronic allograft rejection
9. Immunologic basis of transplant-associated arteriosclerosis
10. Allo- and autotransplantation of carotid artery-a new model of chronic graft vessel disease: Evaluation by magnetic resonance imaging and histology
11. Complete loss of functional smooth muscle cells precedes vascular remodeling in rat aorta allografts
12. Suppression of acute rejection in allogeneic rat lung transplantation: A study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine
13. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
14. Role of endothelium in responses of vascular smooth muscle
15. Effects of forskolin and cyclic nucleotides on isometric force in rat aorta
16. Hydrodynamic injury of the endothelium in acute aortic stenosis
17. Effect of immunosuppression on chronic rejection in the rat aortic allograft model
18. Sequential immunological targeting of chronic experimental arterial allograft
19. Endothelial loss and regeneration in a model of transplant arteriosclerosis
20. Endothelial dysfunction: From physiology to therapy
21. Cyclic nucleotide dependent relaxation in vascular smooth muscle
22. Loss of the coronary microvascular response to acetylcholine in cardiac transplant patients
23. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
24. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation
25. Cytotoxicity of graft-derived lymphocytes: Specific for donor heart endothelial cells?
26. Human heart endothelial-cell-restricted allorecognition
27. Human endothelial cells induce and regulate cytolytic T cell differentiation
28. Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras
29. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin
30. Transplant arterial vasculopathy: Evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia
31. Transplant arteriosclerosis in a rat aortic model
32. Recipient mesenchymal cells infiltrate and remodel medial and adventitial tissue in the rat femoral artery allograft model of chronic vascular rejection
33. Chronic rejection: The result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells?: Data from two rodent models and the effects of immunosuppressive therapies